<GlossaryTerm id="CDR0000468786"><TermName>post-transplant lymphoproliferative disorder</TermName><TermPronunciation>(post-TRANZ-plant LIM-foh-proh-LIH-feh-ruh-tiv dis-OR-der)</TermPronunciation><TermDefinition><DefinitionText>A condition in which a group of B-cells grow out of control after an organ transplant in patients with weakened immune systems. This usually happens if the patient has also been infected with Epstein-Barr virus. Post-transplant lymphoproliferative disorder may progress to non-Hodgkin lymphoma. Also called PTLD.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000716802" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;post-transplant lymphoproliferative disorder&quot;" language="en" id="_3"/><MediaLink ref="CDR0000716803" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;trastorno linfoproliferativo postrasplante&quot;" language="es" id="_4"/><SpanishTermName>trastorno linfoproliferativo postrasplante</SpanishTermName><SpanishTermDefinition><DefinitionText>Afección en la que un grupo de células B se multiplica fuera de control después de un trasplante de órgano en pacientes con un sistema inmunitario debilitado. Suele presentarse en pacientes que además están infectados por el virus de Epstein-Barr. El trastorno linfoproliferativo postrasplante a veces progresa y se convierte en un linfoma no Hodgkin. También se llama enfermedad linfoproliferativa postrasplante y TLPT.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-10-14</DateFirstPublished><DateLastModified>2008-02-19</DateLastModified></GlossaryTerm>
